122 results on '"Björndahl L"'
Search Results
2. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology
- Author
-
Björndahl, L., Barratt, C.L., Mortimer, D., Agarwal, A., Aitken, R.J., Alvarez, J.G., Aneck-Hahn, N., Arver, S., Baldi, E., Bassas, L., Boitrelle, F., Bornman, R., Carrell, D.T., Castilla, J.A., Parra, G. Cerezo, Check, J.H., Cuasnicu, P.S., Darney, S.P., Jager, C., Jonge, C.J. De, Drevet, J.R., Drobnis, E.Z., Plessis, S.S. Du, Eisenberg, M.L., Esteves, S.C., Evgeni, E.A., Ferlin, A., Garrido, N., Giwercman, A., Goovaerts, I.G.F., Haugen, T.B., Henkel, R., Henningsohn, L., Hofmann, M.C., Hotaling, J.M., Jedrzejczak, P., Jouannet, P., Jørgensen, N., Brown, J.C., Krausz, C., Kurpisz, M., Kvist, U., Lamb, D.J., Levine, H., Loveland, K.L., McLachlan, R.I., Mahran, A., Maree, L., Silva, S., Mbizvo, M.T., Meinhardt, A., Menkveld, R., Mortimer, S.T., Moskovtsev, S., Muller, C.H., Munuce, M.J., Muratori, M., Niederberger, C., O'Flaherty, C., Oliva, R., Ombelet, W., Pacey, A.A., Palladino, M.A., Ramasamy, R., Ramos, L., Rives, N., Roldan, E.R., Rothmann, S., Sakkas, D., Salonia, A., Sánchez-Pozo, M.C., Sapiro, R., Schlatt, S., Schlegel, P.N., Schuppe, H.C., Shah, R., Skakkebæk, N.E., Teerds, K., Toskin, I., Tournaye, H., Turek, P.J., Horst, G. ter, Vazquez-Levin, M., Wang, C., Wetzels, A.M.M., Zeginiadou, T., Zini, A., Björndahl, L., Barratt, C.L., Mortimer, D., Agarwal, A., Aitken, R.J., Alvarez, J.G., Aneck-Hahn, N., Arver, S., Baldi, E., Bassas, L., Boitrelle, F., Bornman, R., Carrell, D.T., Castilla, J.A., Parra, G. Cerezo, Check, J.H., Cuasnicu, P.S., Darney, S.P., Jager, C., Jonge, C.J. De, Drevet, J.R., Drobnis, E.Z., Plessis, S.S. Du, Eisenberg, M.L., Esteves, S.C., Evgeni, E.A., Ferlin, A., Garrido, N., Giwercman, A., Goovaerts, I.G.F., Haugen, T.B., Henkel, R., Henningsohn, L., Hofmann, M.C., Hotaling, J.M., Jedrzejczak, P., Jouannet, P., Jørgensen, N., Brown, J.C., Krausz, C., Kurpisz, M., Kvist, U., Lamb, D.J., Levine, H., Loveland, K.L., McLachlan, R.I., Mahran, A., Maree, L., Silva, S., Mbizvo, M.T., Meinhardt, A., Menkveld, R., Mortimer, S.T., Moskovtsev, S., Muller, C.H., Munuce, M.J., Muratori, M., Niederberger, C., O'Flaherty, C., Oliva, R., Ombelet, W., Pacey, A.A., Palladino, M.A., Ramasamy, R., Ramos, L., Rives, N., Roldan, E.R., Rothmann, S., Sakkas, D., Salonia, A., Sánchez-Pozo, M.C., Sapiro, R., Schlatt, S., Schlegel, P.N., Schuppe, H.C., Shah, R., Skakkebæk, N.E., Teerds, K., Toskin, I., Tournaye, H., Turek, P.J., Horst, G. ter, Vazquez-Levin, M., Wang, C., Wetzels, A.M.M., Zeginiadou, T., and Zini, A.
- Abstract
Item does not contain fulltext, Biomedical science is rapidly developing in terms of more transparency, openness and reproducibility of scientific publications. This is even more important for all studies that are based on results from basic semen examination. Recently two concordant documents have been published: the 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, and the International Standard ISO 23162:2021. With these tools, we propose that authors should be instructed to follow these laboratory methods in order to publish studies in peer-reviewed journals, preferable by using a checklist as suggested in an Appendix to this article.
- Published
- 2022
3. Protocol for developing a core outcome set for male infertility research: an international consensus development study.
- Author
-
Rimmer, MP, Howie, RA, Anderson, RA, Barratt, CLR, Barnhart, KT, Beebeejaun, Y, Bertolla, RP, Bhattacharya, S, Björndahl, L, Bortoletto, P, Brannigan, RE, Cantineau, AEP, Caroppo, E, Collura, BL, Coward, K, Eisenberg, ML, De Geyter, C, Goulis, DG, Henkel, RR, Ho, VNA, Hussein, AF, Huyser, C, Kadijk, JH, Kamath, MS, Khashaba, S, Kobori, Y, Kopeika, J, Kucuk, T, Luján, S, Matsaseng, TC, Mathur, RS, McEleny, K, Mitchell, RT, Mol, BW, Murage, AM, Ng, EHY, Pacey, A, Perheentupa, AH, Du Plessis, S, Rives, N, Sarris, I, Schlegel, PN, Shabbir, M, Śmiechowski, M, Subramanian, V, Sunkara, SK, Tarlarzis, BC, Tüttelmann, F, Vail, A, van Wely, M, Vazquez-Levin, MH, Vuong, LN, Wang, AY, Wang, R, Zini, A, Farquhar, CM, Niederberger, C, Duffy, JMN, Rimmer, MP, Howie, RA, Anderson, RA, Barratt, CLR, Barnhart, KT, Beebeejaun, Y, Bertolla, RP, Bhattacharya, S, Björndahl, L, Bortoletto, P, Brannigan, RE, Cantineau, AEP, Caroppo, E, Collura, BL, Coward, K, Eisenberg, ML, De Geyter, C, Goulis, DG, Henkel, RR, Ho, VNA, Hussein, AF, Huyser, C, Kadijk, JH, Kamath, MS, Khashaba, S, Kobori, Y, Kopeika, J, Kucuk, T, Luján, S, Matsaseng, TC, Mathur, RS, McEleny, K, Mitchell, RT, Mol, BW, Murage, AM, Ng, EHY, Pacey, A, Perheentupa, AH, Du Plessis, S, Rives, N, Sarris, I, Schlegel, PN, Shabbir, M, Śmiechowski, M, Subramanian, V, Sunkara, SK, Tarlarzis, BC, Tüttelmann, F, Vail, A, van Wely, M, Vazquez-Levin, MH, Vuong, LN, Wang, AY, Wang, R, Zini, A, Farquhar, CM, Niederberger, C, and Duffy, JMN
- Abstract
STUDY QUESTION: We aim to develop, disseminate and implement a minimum data set, known as a core outcome set, for future male infertility research. WHAT IS KNOWN ALREADY: Research into male infertility can be challenging to design, conduct and report. Evidence from randomized trials can be difficult to interpret and of limited ability to inform clinical practice for numerous reasons. These may include complex issues, such as variation in outcome measures and outcome reporting bias, as well as failure to consider the perspectives of men and their partners with lived experience of fertility problems. Previously, the Core Outcome Measure for Infertility Trials (COMMIT) initiative, an international consortium of researchers, healthcare professionals and people with fertility problems, has developed a core outcome set for general infertility research. Now, a bespoke core outcome set for male infertility is required to address the unique challenges pertinent to male infertility research. STUDY DESIGN SIZE DURATION: Stakeholders, including healthcare professionals, allied healthcare professionals, scientists, researchers and people with fertility problems, will be invited to participate. Formal consensus science methods will be used, including the modified Delphi method, modified Nominal Group Technique and the National Institutes of Health's consensus development conference. PARTICIPANTS/MATERIALS SETTING METHODS: An international steering group, including the relevant stakeholders outlined above, has been established to guide the development of this core outcome set. Possible core outcomes will be identified by undertaking a systematic review of randomized controlled trials evaluating potential treatments for male factor infertility. These outcomes will be entered into a modified Delphi method. Repeated reflection and re-scoring should promote convergence towards consensus outcomes, which will be prioritized during a consensus development meeting to identify a final core
- Published
- 2022
4. Sperm chromatin structure assay and classical semen parameters: systematic review
- Author
-
Castilla, J.A., Zamora, S., Gonzalvo, M.C., Luna del Castillo, J.D., Roldan-Nofuentes, J.A., Clavero, A., Björndahl, L., and Martínez, L.
- Published
- 2010
- Full Text
- View/download PDF
5. P–105 Clinical validation of mojo AISA, an artificial intelligence robotic CASA system
- Author
-
Monteiro, M, primary, Thomas, D, additional, Maillot, R, additional, Simon, Z, additional, Björndahl, L, additional, Flanagan, J, additional, and Taha, M, additional
- Published
- 2021
- Full Text
- View/download PDF
6. P–104 Assessment of sperm motility according to WHO classification using convolutional neural networks
- Author
-
Haugen, T B, primary, Hicks, S A, additional, Witczak, O, additional, Andersen, J M, additional, Björndahl, L, additional, and Riegler, M A, additional
- Published
- 2021
- Full Text
- View/download PDF
7. Proposal of guidelines for the appraisal of SEMen QUAlity studies (SEMQUA)
- Author
-
Sánchez-Pozo, M.C., Mendiola, J., Serrano, M., Mozas, J., Björndahl, L., Menkveld, R., Lewis, S.E.M., Mortimer, D., Jørgensen, N., Barratt, C.L.R., Fernández, M.F., and Castilla, J.A.
- Published
- 2013
- Full Text
- View/download PDF
8. Acceptable variability in external quality assessment programmes for basic semen analysis
- Author
-
Palacios, E.R., Clavero, A., Gonzalvo, M.C., Rosales, A., Mozas, J., Martínez, L., Ramírez, J.P., Björndahl, L., Morancho-Zaragoza, J., Fernández-Pardo, E., and Castilla, J.A.
- Published
- 2012
- Full Text
- View/download PDF
9. ESHRE special interest group for andrology basic semen analysis course: a continued focus on accuracy, quality, efficiency and clinical relevance†
- Author
-
Barratt, C.L.R., Björndahl, L., Menkveld, R., and Mortimer, D.
- Published
- 2011
- Full Text
- View/download PDF
10. Development of a novel home sperm test
- Author
-
Björndahl, L., Kirkman-Brown, J., Hart, G., Rattle, S., and Barratt, C.L.R.
- Published
- 2006
11. Evaluation of the one-step eosin-nigrosin staining technique for human sperm vitality assessment
- Author
-
Björndahl, L., Söderlund, I., and Kvist, U.
- Published
- 2003
12. Semen analysis and external quality control schemes for semen analysis need global standardization
- Author
-
COOPER, T. G., BJÖRNDAHL, L., VREEBURG, J., and NIESCHLAG, E.
- Published
- 2002
13. ESHRE basic semen analysis courses 1995-1999: immediate beneficial effects of standardized training
- Author
-
Björndahl, L., Barratt, C. L.R., Fraser, L. R., Kvist, U., and Mortimer, D.
- Published
- 2002
14. Compliance with recommendations for reliable semen analysis results - a matter of importance for patients and scientific development
- Author
-
Björndahl, L., primary
- Published
- 2016
- Full Text
- View/download PDF
15. 157 Selection of spermatozoa for assisted reproduction involves a hitherto ignored and uncontrolled hypotonic shock that affects basic sperm volume control and sperm motility
- Author
-
Holmes, E., primary, Björndahl, L., additional, and Kvist, U., additional
- Published
- 2014
- Full Text
- View/download PDF
16. 255 Impact of age, days of abstinence, and BMI on results of semen analysis from men of sub-fertile couples
- Author
-
Flanagan, J., primary, Lehtihet, M., additional, Björndahl, L., additional, Arver, S., additional, and Kvist, U., additional
- Published
- 2014
- Full Text
- View/download PDF
17. Rapid and slow hydroxylators of seminal E prostaglandins among men in barren unions
- Author
-
Pourian, M. R., primary, Kvist, U., additional, Björndahl, L., additional, and Oliw, E. H., additional
- Published
- 2009
- Full Text
- View/download PDF
18. Development of a novel home sperm test
- Author
-
Björndahl, L., primary, Kirkman-Brown, J., additional, Hart, G., additional, Rattle, S., additional, and Barratt, C.L.R., additional
- Published
- 2005
- Full Text
- View/download PDF
19. Sperm chromatin stability and zinc binding properties in semen from men in barren unions
- Author
-
KJELLBERG, S., primary, BJÖRNDAHL, L., additional, and KVISTt, U., additional
- Published
- 1992
- Full Text
- View/download PDF
20. Ejaculatory sequence in men with low sperm chromatin-zinc
- Author
-
BJÖRNDAHL, L., primary, KJELLBERG, S., additional, and KVIST, U., additional
- Published
- 1991
- Full Text
- View/download PDF
21. Seminal fluid from men with agenesis of the Wolffian ducts: zinc-binding properties and effects on sperm chromatin stability
- Author
-
KVIST, U., primary, KJELLBERG, S., additional, BJÖRNDAHL, L., additional, SOUFIR, J.-C., additional, and ARVER, S., additional
- Published
- 1990
- Full Text
- View/download PDF
22. Removal of zinc from subcellular regions of human spermatozoa by EDTA treatment studied by X-ray microanalysis.
- Author
-
Roomans, G. M., Lundevall, E., Björndahl, L., and Kvist, U.
- Published
- 1982
- Full Text
- View/download PDF
23. Andrology. ESHRE basic semen analysis courses 1995–1999: immediate beneficial effects of standardized training
- Author
-
Björndahl, L., Barratt, C.L.R., Fraser, L.R., Kvist, U., and Mortimer, D.
- Abstract
BACKGROUND: Many reports have shown problems with the high variability in results of semen analyses. The Special Interest Group in Andrology (SIGA) of the European Society of Human Reproduction and Embryology (ESHRE) implemented a standardized training course which has been run in different regions of the world on more than 20 occasions since 1994. The aim of the present analysis was to investigate to what extent training resulted in any immediate effects on the variability of assessments made by different observers. METHODS: The variability in participants' results from the beginning to the end of each course was analysed in eight courses given between 1995 and 1999. RESULTS: For assessments of sperm concentration, motility, vitality and morphology, substantial improvement was seen over the duration of the course. CONCLUSIONS: A comprehensive, structured training course does lead to substantial reductions in inter-observer variability in semen analysis. This supports our contention that providing a thorough theoretical background and repeated practical training, combined with daily feedback of results, is highly effective in raising the technical skills of laboratory personnel performing semen analysis.
- Published
- 2002
24. Chiropractic care may influence proprioceptive sensation and pain of cervical origin.
- Author
-
Lawrence DJ, Palmgren PJ, and Björndahl L
- Published
- 2006
25. Effect of chiropractic treatment on hip extension ability and running velocity among young male running athletes.
- Author
-
Sandell J, Palmgren PJ, and Björndahl L
- Published
- 2007
26. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology
- Author
-
Lars Björndahl, Christopher L R Barratt, David Mortimer, Ashok Agarwal, Robert J Aitken, Juan G Alvarez, Natalie Aneck-Hahn, Stefan Arver, Elisabetta Baldi, Lluís Bassas, Florence Boitrelle, Riana Bornman, Douglas T Carrell, José A Castilla, Gerardo Cerezo Parra, Jerome H Check, Patricia S Cuasnicu, Sally Perreault Darney, Christiaan de Jager, Christopher J De Jonge, Joël R Drevet, Erma Z Drobnis, Stefan S Du Plessis, Michael L Eisenberg, Sandro C Esteves, Evangelini A Evgeni, Alberto Ferlin, Nicolas Garrido, Aleksander Giwercman, Ilse G F Goovaerts, Trine B Haugen, Ralf Henkel, Lars Henningsohn, Marie-Claude Hofmann, James M Hotaling, Piotr Jedrzejczak, Pierre Jouannet, Niels Jørgensen, Jackson C Kirkman Brown, Csilla Krausz, Maciej Kurpisz, Ulrik Kvist, Dolores J Lamb, Hagai Levine, Kate L Loveland, Robert I McLachlan, Ali Mahran, Liana Maree, Sarah Martins da Silva, Michael T Mbizvo, Andreas Meinhardt, Roelof Menkveld, Sharon T Mortimer, Sergey Moskovtsev, Charles H Muller, Maria José Munuce, Monica Muratori, Craig Niederberger, Cristian O’Flaherty, Rafael Oliva, Willem Ombelet, Allan A Pacey, Michael A Palladino, Ranjith Ramasamy, Liliana Ramos, Nathalie Rives, Eduardo Rs Roldan, Susan Rothmann, Denny Sakkas, Andrea Salonia, Maria Cristina Sánchez-Pozo, Rosanna Sapiro, Stefan Schlatt, Peter N Schlegel, Hans-Christian Schuppe, Rupin Shah, Niels E Skakkebæk, Katja Teerds, Igor Toskin, Herman Tournaye, Paul J Turek, Gerhard van der Horst, Monica Vazquez-Levin, Christina Wang, Alex Wetzels, Theodosia Zeginiadou, Armand Zini, Faculty of Medicine and Pharmacy, Clinical sciences, Biology of the Testis, Centre for Reproductive Medicine - Gynaecology, Génétique, Reproduction et Développement (GReD), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])-Centre National de la Recherche Scientifique (CNRS), CHU Rouen, Normandie Université (NU), UNIROUEN - UFR Santé (UNIROUEN UFR Santé), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU), Neuroendocrine, Endocrine and Germinal Differentiation Communication (NorDic), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Björndahl, L, Barratt, Clr, Mortimer, D, Agarwal, A, Aitken, Rj, Alvarez, Jg, Aneck-Hahn, N, Arver, S, Baldi, E, Bassas, L, Boitrelle, F, Bornman, R, Carrell, Dt, Castilla, Ja, Cerezo Parra, G, Check, Jh, Cuasnicu, P, Darney, Sp, de Jager, C, De Jonge, Cj, Drevet, Jr, Drobnis, Ez, Du Plessis, S, Eisenberg, Ml, Esteves, Sc, Evgeni, Ea, Ferlin, A, Garrido, N, Giwercman, A, Goovaerts, Igf, Haugen, Tb, Henkel, R, Henningsohn, L, Hofmann, Mc, Hotaling, Jm, Jedrzejczak, P, Jouannet, P, Jørgensen, N, Kirkman Brown, Jc, Krausz, C, Kurpisz, M, Kvist, U, Lamb, Dj, Levine, H, Loveland, Kl, Mclachlan, Ri, Mahran, A, Maree, L, Martins da Silva, S, Mbizvo, Mt, Meinhardt, A, Menkveld, R, Mortimer, St, Moskovtsev, S, Muller, Ch, Munuce, Mj, Muratori, M, Niederberger, C, O'Flaherty, C, Oliva, R, Ombelet, W, Pacey, Aa, Palladino, Ma, Ramasamy, R, Ramos, L, Rives, N, Roldan, Er, Rothmann, S, Sakkas, D, Salonia, A, Sánchez-Pozo, Mc, Sapiro, R, Schlatt, S, Schlegel, Pn, Schuppe, Hc, Shah, R, Skakkebæk, Ne, Teerds, K, Toskin, I, Tournaye, H, Turek, Pj, van der Horst, G, Vazquez-Levin, M, Wang, C, Wetzels, A, Zeginiadou, T, Zini, A., Pacey, Allan/0000-0002-4387-8871, Arver, Stefan/0000-0002-2925-355X, Mortimer, David/0000-0002-0638-2893, Barratt, christopher/0000-0003-0062-9979, Kirkman-Brown, Jackson, C/0000-0003-2833-8970, Bjorndahl, Lars/0000-0002-4709-5807, Baldi, Elisabetta/0000-0003-1808-3097, Aitken, Robert John/0000-0002-9152-156X, Bjorndahl, Lars, Barratt, Christopher L. R., Mortimer, David, Agarwal, Ashok, Aitken, Robert J., Alvarez, Juan G., Aneck-Hahn, Natalie, Arver, Stefan, Baldi, Elisabetta, Bassas, Lluis, Boitrelle, Florence, Bornman, Riana, Carrell, Douglas T., Castilla, Jose A., Cerezo Parra, Gerardo, Check, Jerome H., Cuasnicu, Patricia S., Darney, Sally Perreault, de Jager, Christiaan, De Jonge, Christopher J., Drevet, Joel R., Drobnis, Erma Z., Du Plessis, Stefan S., Eisenberg, Michael L., Esteves, Sandro C., Evgeni, Evangelini A., Ferlin, Alberto, Garrido, Nicolas, Giwercman, Aleksander, Goovaerts, Ilse G. F., Haugen, Trine B., Henkel, Ralf, Henningsohn, Lars, Hofmann, Marie-Claude, Hotaling, James M., Jedrzejczak, Piotr, Jouannet, Pierre, Jorgensen, Niels, Brown, Jackson C. Kirkman, Krausz, Csilla, Kurpisz, Maciej, Kvist, Ulrik, Lamb, Dolores J., Levine, Hagai, Loveland, Kate L., McLachlan, Robert, I, Mahran, Ali, Maree, Liana, da Silva, Sarah Martins, Mbizvo, Michael T., Meinhardt, Andreas, Menkveld, Roelof, Mortimer, Sharon T., Moskovtsev, Sergey, Muller, Charles H., Jose Munuce, Maria, Muratori, Monica, Niederberger, Craig, O'Flaherty, Cristian, Oliva, Rafael, OMBELET, Willem, Pacey, Allan A., Palladino, Michael A., Ramasamy, Ranjith, Ramos, Liliana, Rives, Nathalie, Roldan, Eduardo Rs, Rothmann, Susan, Sakkas, Denny, Salonia, Andrea, Cristina Sanchez-Pozo, Maria, Sapiro, Rosanna, Schlatt, Stefan, Schlegel, Peter N., Schuppe, Hans-Christian, Shah, Rupin, Skakkebaek, Niels E., Teerds, Katja, Toskin, Igor, Tournaye, Herman, Turek, Paul J., van der Horst, Gerhard, Vazquez-Levin, Monica, Wang, Christina, Wetzels, Alex, Zeginiadou, Theodosia, and Zini, Armand
- Subjects
Reproducitibility ,[SDV]Life Sciences [q-bio] ,andrology ,basic semen examination ,journal requirements ,laboratory training ,patient security ,quality control ,reproducibility ,reproductive medicine ,science development ,standardized laboratory procedures ,Humans ,Reproducibility of Results ,Publishing ,Semen ,Semen Analysis ,Andrology ,Obstetrics & Reproductive Medicine ,Biology ,11 Medical and Health Sciences ,Reproductive Biology ,Science & Technology ,Rehabilitation ,Obstetrics & Gynecology ,Obstetrics and Gynecology ,Reproductive Medicine ,16 Studies in Human Society ,Human and Animal Physiology ,Fysiologie van Mens en Dier ,Human medicine ,Life Sciences & Biomedicine - Abstract
Biomedical science is rapidly developing in terms of more transparency, openness and reproducibility of scientific publications. This is even more important for all studies that are based on results from basic semen examination. Recently two concordant documents have been published: the 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, and the International Standard ISO 23162:2021. With these tools, we propose that authors should be instructed to follow these laboratory methods in order to publish studies in peer-reviewed journals, preferable by using a checklist as suggested in an Appendix to this article.
- Published
- 2022
27. What is required for better progress in clinical and scientific andrology involving sperm assessments?
- Author
-
Björndahl L
- Subjects
- Humans, Male, Infertility, Male diagnosis, Infertility, Male therapy, Andrology, Semen Analysis methods, Spermatozoa physiology
- Published
- 2024
- Full Text
- View/download PDF
28. Presence of key cholinergic enzymes in human spermatozoa and seminal fluid†.
- Author
-
Thakur B, Hasooni LP, Gera R, Mitra S, Björndahl L, and Darreh-Shori T
- Subjects
- Humans, Male, Butyrylcholinesterase metabolism, Semen metabolism, Sperm Motility, Spermatozoa metabolism, Cholinergic Agents, Acetylcholinesterase genetics, Acetylcholinesterase metabolism, Acetylcholine
- Abstract
Little is known about the non-neuronal spermic cholinergic system, which may regulate sperm motility and the acrosome reaction initiation process. We investigated the presence of the key acetylcholine (ACh)-biosynthesizing enzyme, choline acetyltransferase (ChAT), and the acetylcholine-degrading enzymes, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) and two ACh-receptors in human spermatozoa and seminal plasma. Fresh ejaculates were used for intra- and extracellular flow cytometric analysis of ChAT, AChE, BChE, and alpha-7-nicotinic and M1-muscarinic ACh-receptors in sperm. For determining the source of soluble enzymes, frozen seminal samples (n = 74) were selected on two bases: (1) from vasectomized (n = 37) and non-vasectomized (n = 37) subjects and (2) based on levels of alpha-glucosidase, fructose, or zinc to define sample subgroups with high or low fluid contribution from the epididymis and seminal vesicle, and prostate, respectively. Flow cytometric analyses revealed that ChAT was expressed intracellularly in essentially all spermatozoa. ChAT was also present in a readily membrane-detachable form at the extracellular membrane of at least 18% of the spermatozoa. These were also highly positive for intra- and extracellular BChE (>83%) and M1 (>84%) and α7 (>59%) ACh-receptors. Intriguingly, the sperm was negative for AChE. Analyses of seminal plasma revealed that spermatozoa and epididymides were major sources of soluble ChAT and BChE, whereas soluble AChE most likely originated from epididymides and seminal vesicles. Prostate had relatively minor contribution to the pool of the soluble enzymes in the seminal fluid. In conclusion, human spermatozoa exhibited a cholinergic phenotype and were one of the major sources of soluble ChAT and BChE in ejaculate. We also provide the first evidence for ChAT as an extracellularly membrane-anchored protein., (© The Author(s) 2023. Published by Oxford University Press on behalf of Society for the Study of Reproduction.)
- Published
- 2024
- Full Text
- View/download PDF
29. Improving standard practices in studies using results from basic human semen examination.
- Author
-
Björndahl L, Esteves SC, Ferlin A, Jørgensen N, and O'Flaherty C
- Subjects
- Humans, Male, Semen, Semen Analysis methods, Fertility, Infertility, Andrology, Infertility, Male diagnosis
- Abstract
The purpose of this article is to provide an explanation of the background behind a checklist that declares the laboratory methods used in a scientific study. It focuses primarily on implementing laboratory procedures to yield reliable results in basic semen examinations. While the World Health Organization (WHO) and international standards provide recommendations for basic semen examination, manuscripts submitted to Andrology frequently lack transparency regarding the specific techniques used. In addition, the terminology used for semen examination results often fails to provide a clear definition of the groups under study. Furthermore, the WHO's reference limits are often misinterpreted as strict boundaries between fertility and infertility. It is important to note that valid clinical andrological diagnoses and treatments cannot rely solely on semen examination results; they require proper laboratory procedures as a foundation for diagnosing and treating male patients. Therefore, scientific journals should promote the adoption of robust laboratory practices and an accurate definition of patient groups. A checklist can facilitate the design of high-quality studies and the creation of informative publications. Further, it can help journals assess submitted manuscripts and improve the overall quality of their publications., (© 2023 The Authors. Andrology published by Wiley Periodicals LLC on behalf of American Society of Andrology and European Academy of Andrology.)
- Published
- 2023
- Full Text
- View/download PDF
30. Sperm motility assessed by deep convolutional neural networks into WHO categories.
- Author
-
Haugen TB, Witczak O, Hicks SA, Björndahl L, Andersen JM, and Riegler MA
- Subjects
- Male, Humans, Semen Analysis, Neural Networks, Computer, World Health Organization, Sperm Motility, Semen
- Abstract
Semen analysis is central in infertility investigation. Manual assessment of sperm motility according to the WHO recommendations is the golden standard, and extensive training is a requirement for accurate and reproducible results. Deep convolutional neural networks (DCNN) are especially suitable for image classification. In this study, we evaluated the performance of the DCNN ResNet-50 in predicting the proportion of sperm in the WHO motility categories. Two models were evaluated using tenfold cross-validation with 65 video recordings of wet semen preparations from an external quality assessment programme for semen analysis. The corresponding manually assessed data was obtained from several of the reference laboratories, and the mean values were used for training of the DCNN models. One model was trained to predict the three categories progressive motility, non-progressive motility, and immotile spermatozoa. Another model was used in predicting four categories, where progressive motility was differentiated into rapid and slow. The resulting average mean absolute error (MAE) was 0.05 and 0.07, and the average ZeroR baseline was 0.09 and 0.10 for the three-category and the four-category model, respectively. Manual and DCNN-predicted motility was compared by Pearson's correlation coefficient and by difference plots. The strongest correlation between the mean manually assessed values and DCNN-predicted motility was observed for % progressively motile spermatozoa (Pearson's r = 0.88, p < 0.001) and % immotile spermatozoa (r = 0.89, p < 0.001). For rapid progressive motility, the correlation was moderate (Pearson's r = 0.673, p < 0.001). The median difference between manual and predicted progressive motility was 0 and 2 for immotile spermatozoa. The largest bias was observed at high and low percentages of progressive and immotile spermatozoa. The DCNN-predicted value was within the range of the interlaboratory variation of the results for most of the samples. In conclusion, DCNN models were able to predict the proportion of spermatozoa into the WHO motility categories with significantly lower error than the baseline. The best correlation between the manual and the DCNN-predicted motility values was found for the categories progressive and immotile. Of note, there was considerable variation between the mean motility values obtained for each category by the reference laboratories, especially for rapid progressive motility, which impacts the training of the DCNN models., (© 2023. Springer Nature Limited.)
- Published
- 2023
- Full Text
- View/download PDF
31. Topical reinforcement of the cervical mucus barrier to sperm.
- Author
-
Schimpf U, Caldas-Silveira E, Katchan L, Vigier-Carriere C, Lantier I, Nachmann G, Gidlöf S, Jonasson AF, Björndahl L, Trombotto S, Druart X, and Crouzier T
- Subjects
- Humans, Pregnancy, Male, Animals, Female, Sheep, Sperm Motility, Semen, Spermatozoa, Contraceptive Agents, Cervix Mucus, Chitosan
- Abstract
Close to half of the world's pregnancies are still unplanned, reflecting a clear unmet need in contraception. Ideally, a contraceptive would provide the high efficacy of hormonal treatments, without systemic side effects. Here, we studied topical reinforcement of the cervical mucus by chitosan mucoadhesive polymers as a form of female contraceptive. Chitosans larger than 7 kDa effectively cross-linked human ovulatory cervical mucus to prevent sperm penetration in vitro. We then demonstrated in vivo using the ewe as a model that vaginal gels containing chitosan could stop ram sperm at the entrance of the cervical canal and prevent them from reaching the uterus, whereas the same gels without chitosan did not substantially limit sperm migration. Chitosan did not affect sperm motility in vitro or in vivo, suggesting reinforcement of the mucus physical barrier as the primary mechanism of action. The chitosan formulations did not damage or irritate the ewe vaginal epithelium, in contrast to nonoxynol-9 spermicide. The demonstration that cervical mucus can be reinforced topically to create an effective barrier to sperm may therefore form the technological basis for muco-cervical barrier contraceptives with the potential to become an alternative to hormonal contraceptives.
- Published
- 2022
- Full Text
- View/download PDF
32. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology.
- Author
-
Björndahl L, Barratt CLR, Mortimer D, Agarwal A, Aitken RJ, Alvarez JG, Aneck-Hahn N, Arver S, Baldi E, Bassas L, Boitrelle F, Bornman R, Carrell DT, Castilla JA, Cerezo Parra G, Check JH, Cuasnicu PS, Darney SP, de Jager C, De Jonge CJ, Drevet JR, Drobnis EZ, Du Plessis SS, Eisenberg ML, Esteves SC, Evgeni EA, Ferlin A, Garrido N, Giwercman A, Goovaerts IGF, Haugen TB, Henkel R, Henningsohn L, Hofmann MC, Hotaling JM, Jedrzejczak P, Jouannet P, Jørgensen N, Kirkman Brown JC, Krausz C, Kurpisz M, Kvist U, Lamb DJ, Levine H, Loveland KL, McLachlan RI, Mahran A, Maree L, Martins da Silva S, Mbizvo MT, Meinhardt A, Menkveld R, Mortimer ST, Moskovtsev S, Muller CH, Munuce MJ, Muratori M, Niederberger C, O'Flaherty C, Oliva R, Ombelet W, Pacey AA, Palladino MA, Ramasamy R, Ramos L, Rives N, Roldan ER, Rothmann S, Sakkas D, Salonia A, Sánchez-Pozo MC, Sapiro R, Schlatt S, Schlegel PN, Schuppe HC, Shah R, Skakkebæk NE, Teerds K, Toskin I, Tournaye H, Turek PJ, van der Horst G, Vazquez-Levin M, Wang C, Wetzels A, Zeginiadou T, and Zini A
- Subjects
- Humans, Reproducibility of Results, Peer Review, Publishing, Semen, Semen Analysis methods
- Abstract
Biomedical science is rapidly developing in terms of more transparency, openness and reproducibility of scientific publications. This is even more important for all studies that are based on results from basic semen examination. Recently two concordant documents have been published: the 6th edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen, and the International Standard ISO 23162:2021. With these tools, we propose that authors should be instructed to follow these laboratory methods in order to publish studies in peer-reviewed journals, preferable by using a checklist as suggested in an Appendix to this article., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.)
- Published
- 2022
- Full Text
- View/download PDF
33. A paradigmatic shift in the care of male factor infertility: how can the recommendations for basic semen examination in the sixth edition of the WHO manual and the ISO 23162:2021 standard help?
- Author
-
Björndahl L
- Subjects
- Female, Humans, Male, Pregnancy, Semen, Semen Analysis, Sperm Count, Sperm Motility, Spermatozoa, World Health Organization, Contraceptive Agents, Male, Infertility, Male diagnosis, Infertility, Male therapy
- Abstract
The WHO laboratory manual for the examination and processing of human semen is a worldwide recognized source of information on reliable techniques for semen examination. Since its initial publication, aimed at providing useful data in the evaluation of male contraceptive drugs, the manual has developed to focus mainly on discovering male factors of infertility as a basis for medical assisted reproduction. The principles for basic semen examination remain mainly unchanged in the sixth edition. Some important adjustments have been made to improve efficacy, compliance with basic laboratory science and user-friendly instructions. For human sperm morphology assessment, more rationale and techniques are given for the assessment of defects in all parts of the spermatozoa. More data from men in couples with less than 1 year to initiation of pregnancy have been incorporated into the manual. The general problem, however, has been that these ranges and limits have been misinterpreted as distinct limits between fertility and infertility. This review discusses how the available distribution of data from men in couples achieving pregnancy should be interpreted. Another important aspect is the use of human sperm morphology for better understanding of functions and disorders of the male reproductive organs to increase the focus on men's reproductive health., (Copyright © 2022 The Author. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
34. Protocol for developing a core outcome set for male infertility research: an international consensus development study.
- Author
-
Rimmer MP, Howie RA, Anderson RA, Barratt CLR, Barnhart KT, Beebeejaun Y, Bertolla RP, Bhattacharya S, Björndahl L, Bortoletto P, Brannigan RE, Cantineau AEP, Caroppo E, Collura BL, Coward K, Eisenberg ML, De Geyter C, Goulis DG, Henkel RR, Ho VNA, Hussein AF, Huyser C, Kadijk JH, Kamath MS, Khashaba S, Kobori Y, Kopeika J, Kucuk T, Luján S, Matsaseng TC, Mathur RS, McEleny K, Mitchell RT, Mol BW, Murage AM, Ng EHY, Pacey A, Perheentupa AH, Du Plessis S, Rives N, Sarris I, Schlegel PN, Shabbir M, Śmiechowski M, Subramanian V, Sunkara SK, Tarlarzis BC, Tüttelmann F, Vail A, van Wely M, Vazquez-Levin MH, Vuong LN, Wang AY, Wang R, Zini A, Farquhar CM, Niederberger C, and Duffy JMN
- Abstract
Study Question: We aim to develop, disseminate and implement a minimum data set, known as a core outcome set, for future male infertility research., What Is Known Already: Research into male infertility can be challenging to design, conduct and report. Evidence from randomized trials can be difficult to interpret and of limited ability to inform clinical practice for numerous reasons. These may include complex issues, such as variation in outcome measures and outcome reporting bias, as well as failure to consider the perspectives of men and their partners with lived experience of fertility problems. Previously, the Core Outcome Measure for Infertility Trials (COMMIT) initiative, an international consortium of researchers, healthcare professionals and people with fertility problems, has developed a core outcome set for general infertility research. Now, a bespoke core outcome set for male infertility is required to address the unique challenges pertinent to male infertility research., Study Design Size Duration: Stakeholders, including healthcare professionals, allied healthcare professionals, scientists, researchers and people with fertility problems, will be invited to participate. Formal consensus science methods will be used, including the modified Delphi method, modified Nominal Group Technique and the National Institutes of Health's consensus development conference., Participants/materials Setting Methods: An international steering group, including the relevant stakeholders outlined above, has been established to guide the development of this core outcome set. Possible core outcomes will be identified by undertaking a systematic review of randomized controlled trials evaluating potential treatments for male factor infertility. These outcomes will be entered into a modified Delphi method. Repeated reflection and re-scoring should promote convergence towards consensus outcomes, which will be prioritized during a consensus development meeting to identify a final core outcome set. We will establish standardized definitions and recommend high-quality measurement instruments for individual core outcomes., Study Funding/competing Interests: This work has been supported by the Urology Foundation small project award, 2021. C.L.R.B. is the recipient of a BMGF grant and received consultancy fees from Exscentia and Exceed sperm testing, paid to the University of Dundee and speaking fees or honoraria paid personally by Ferring, Copper Surgical and RBMO. S.B. received royalties from Cambridge University Press, Speaker honoraria for Obstetrical and Gynaecological Society of Singapore, Merk SMART Masterclass and Merk FERRING Forum, paid to the University of Aberdeen. Payment for leadership roles within NHS Grampian, previously paid to self, now paid to University of Aberdeen. An Honorarium is received as Editor in Chief of Human Reproduction Open. M.L.E. is an advisor to the companies Hannah and Ro. B.W.M. received an investigator grant from the NHMRC, No: GNT1176437 is a paid consultant for ObsEva and has received research funding from Ferring and Merck. R.R.H. received royalties from Elsevier for a book, consultancy fees from Glyciome, and presentation fees from GryNumber Health and Aytu Bioscience. Aytu Bioscience also funded MiOXYS systems and sensors. Attendance at Fertility 2020 and Roadshow South Africa by Ralf Henkel was funded by LogixX Pharma Ltd. R.R.H. is also Editor in Chief of Andrologia and has been an employee of LogixX Pharma Ltd. since 2020. M.S.K. is an associate editor with Human Reproduction Open . K.Mc.E. received an honoraria for lectures from Bayer and Pharmasure in 2019 and payment for an ESHRE grant review in 2019. His attendance at ESHRE 2019 and AUA 2019 was sponsored by Pharmasure and Bayer, respectively. The remaining authors declare no competing interests., Trial Registration Number: Core Outcome Measures in Effectiveness Trials (COMET) initiative registration No: 1586. Available at www.comet-initiative.org/Studies/Details/1586., Trial Registration Date: N/A., Date of First Patient’s Enrolment: N/A., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.)
- Published
- 2022
- Full Text
- View/download PDF
35. The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates.
- Author
-
Björndahl L and Kirkman Brown J
- Subjects
- Fertility, Humans, Infertility, Male pathology, Infertility, Male physiopathology, Male, Predictive Value of Tests, Quality Assurance, Health Care standards, Quality Control, Quality Indicators, Health Care standards, Reproducibility of Results, Ejaculation, Infertility, Male diagnosis, Manuals as Topic standards, Semen Analysis standards, Spermatozoa pathology, World Health Organization
- Abstract
A basic semen investigation has established principles that are necessary for ascertaining reliable and internationally comparable results. Although these principles have been present in the WHO manual since its inception, the baseline issue across most published studies and practice in reproductive medicine (in which the male is considered) is repetitive failure to adhere to these principles, thereby leading to relevant comparable data and accuracy. To address this failure, the sixth edition of the WHO manual includes revised basic methods, and a complementary formal standard of the International Standards Organization (ISO23162:2021) for basic semen examination has been published. Perhaps the most significant change in the sixth edition is the reintroduction of the four-category distinction of sperm motility, which causes additional work for laboratories in changing reporting parameters but is clinically important. Another essential change is the widened focus from mainly a prognostic tool for medically assisted reproduction to additionally raising awareness of semen examination as a measure of male reproductive functions and general male health., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
36. Evolution of the WHO "Semen" processing manual from the first (1980) to the sixth edition (2021).
- Author
-
Wang C, Mbizvo M, Festin MP, Björndahl L, and Toskin I
- Subjects
- Diffusion of Innovation, Fertility, History, 20th Century, History, 21st Century, Humans, Infertility, Male history, Infertility, Male pathology, Infertility, Male physiopathology, Male, Infertility, Male diagnosis, Manuals as Topic standards, Semen Analysis history, Semen Analysis standards, Semen Analysis trends, Spermatozoa pathology, World Health Organization history
- Abstract
As stated clearly in all editions of the WHO Laboratory Manual for the Examination and Processing of Human Semen, the goal of the manual is to meet the growing needs for the standardization of semen analysis procedures. With constant advances in andrology and reproductive medicine and the advent of sophisticated assisted reproductive technologies for the treatment of infertility, the manual has been continuously updated to meet the need for new, evidence-based, validated tests to not only measure semen and sperm variables but also to provide a functional assessment of spermatozoa. The sixth edition of the WHO manual, launched in 2021, can be freely downloaded from the WHO website, with the hope of gaining wide acceptance and utilization as the essential source of the latest, evidence-based information for laboratory procedures required for the assessment of male reproductive function and health., (Copyright © 2021 American Society for Reproductive Medicine. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
37. Distribution of semen examination results 2020 - A follow up of data collated for the WHO semen analysis manual 2010.
- Author
-
Campbell MJ, Lotti F, Baldi E, Schlatt S, Festin MPR, Björndahl L, Toskin I, and Barratt CLR
- Subjects
- Follow-Up Studies, Humans, Male, Reference Values, World Health Organization, Semen Analysis statistics & numerical data
- Abstract
Background: It is now 11 years since publication of the WHO 2010 guidelines for semen assessment values, and it is critical to determine whether they are still valid and/or whether they should be modified., Objectives: To utilise data published since 2010 and combine these with data used in the 2010 assessment to provide an updated and more comprehensive representation of the fertile man. This may be utilised to present an updated distribution of values for use by WHO in 2021., Materials and Methods: Two specific analyses were performed namely, (1) Analysis 1: Examination of published data following publication of WHO 2010 [termed 2010-2020 data]. (2) Analysis 2: Examination of the data used to help formulate the 2010 distribution of values combined with the data from Analysis (1) [termed WHO 2020]., Results: In total, data from more than 3500 subjects, from twelve countries and five continents were analysed. The 5
th centile values for concentration, motility and morphology are: 16 × 106 /ml, 30% progressive motility [42% total motility] and 4% normal forms., Discussion: This study presents substantial additional information to establish more comprehensive and globally applicable lower reference values for semen parameters for fertile men although they do not represent distinct limits between fertile and subfertile men. There are still data missing from many countries and, some geographical regions are not represented. Moreover, the number of subjects although significant is still relatively low (<4000)., Conclusion: These distributions of values now include semen analysis providing a more global representation of the fertile man. Increasing the number of subjects provides robust information that is also more geographically representative., (© 2021 American Society of Andrology and European Academy of Andrology.)- Published
- 2021
- Full Text
- View/download PDF
38. SARS-CoV-2 pandemic and repercussions for male infertility patients: A proposal for the individualized provision of andrological services.
- Author
-
Esteves SC, Lombardo F, Garrido N, Alvarez J, Zini A, Colpi GM, Kirkman-Brown J, Lewis SEM, Björndahl L, Majzoub A, Cho CL, Vendeira P, Hallak J, Amar E, Cocuzza M, Bento FC, Figueira RC, Sciorio R, Laursen RJ, Metwalley AM, Jindal SK, Parekattil S, Ramasamy R, Alviggi C, Humaidan P, Yovich JL, and Agarwal A
- Subjects
- Humans, Infertility, Male diagnosis, Infertility, Male physiopathology, Male, Andrology organization & administration, COVID-19, Health Services Accessibility organization & administration, Health Services Needs and Demand organization & administration, Infertility, Male therapy, Needs Assessment organization & administration
- Abstract
The prolonged lockdown of health facilities providing non-urgent gamete cryopreservation-as currently recommended by many reproductive medicine entities and regulatory authorities due to the SARS-CoV-2 pandemic will be detrimental for subgroups of male infertility patients. We believe the existing recommendations should be promptly modified and propose that the same permissive approach for sperm banking granted for men with cancer is expanded to other groups of vulnerable patients. These groups include infertility patients (eg, azoospermic and cryptozoospermic) undergoing medical or surgical treatment to improve sperm quantity and quality, as well as males of reproductive age affected by inflammatory and systemic auto-immune diseases who are about to start treatment with gonadotoxic drugs or who are under remission. In both scenarios, the "fertility window" may be transitory; postponing diagnostic semen analysis and sperm banking in these men could compromise the prospects of biological parenthood. Moreover, we provide recommendations on how to continue the provision of andrological services in a considered manner and a safe environment. Our opinion is timely and relevant given the fact that fertility services are currently rated as of low priority in most countries., (© 2020 American Society of Andrology and European Academy of Andrology.)
- Published
- 2021
- Full Text
- View/download PDF
39. Hypotonic challenge reduces human sperm motility through coiling and folding of the tail.
- Author
-
Holmes E, Björndahl L, and Kvist U
- Subjects
- Humans, Male, Osmolar Concentration, Sperm Tail, Sperm Motility, Spermatozoa
- Abstract
Human ejaculates collected for in vitro procedures show variably rapid increases in osmolality, depending on enzymatic degradation of compounds. Changes in osmolality can affect cell functions due to the energy consuming processes needed to control cell volume. The aim was to examine the effects of a hypotonic challenge for spermatozoa exposed to increased osmolality. Spermatozoa were selected by density gradient centrifugation and washed in media with different osmolalities. Osmolality was measured by freezing-point depression and sperm velocities by CASA. Swimming pattern observations and assessments of tail morphology of fixed spermatozoa were done with phase contrast microscopy. Increased osmolality did not change the curvilinear velocity (VCL), while decreased osmolality reduced or abolished VCL nonreversibly. For spermatozoa first exposed to 400 mOsm/kg, reversal of osmolality to 290 mOsm/kg reduced the VCL and the average path velocity (VAP) permanently. Hypotonic challenges increased sperm tail coiling and folding in a dose-response pattern. Spermatozoa once adjusted to high osmolality in the liquefied ejaculate are likely to suffer if exposed to a medium with a lower osmolality. For improved success of Assisted Reproductive Technologies (ART), it appears to be important to minimise the duration of sperm exposure to the ejaculate, by early dilution or sperm preparation., (© 2020 The Authors. Andrologia published by Wiley-VCH GmbH.)
- Published
- 2020
- Full Text
- View/download PDF
40. Esomeprazole reduces sperm motility index by targeting the spermic cholinergic machinery: A mechanistic study for the association between use of proton pump inhibitors and reduced sperm motility index.
- Author
-
Kumar A, Kumar R, Flanagan J, Långström B, Björndahl L, and Darreh-Shori T
- Subjects
- Adult, Choline metabolism, Choline pharmacology, Choline O-Acetyltransferase chemistry, Dose-Response Relationship, Drug, Humans, Male, Protein Binding drug effects, Protein Binding physiology, Protein Structure, Secondary, Protein Structure, Tertiary, Sperm Motility physiology, Spermatozoa drug effects, Spermatozoa metabolism, Choline O-Acetyltransferase metabolism, Esomeprazole metabolism, Esomeprazole pharmacology, Proton Pump Inhibitors metabolism, Proton Pump Inhibitors pharmacology, Sperm Motility drug effects
- Abstract
Recent studies have linked prolonged use of the most commonly prescribed proton pump inhibitors (PPIs) with declined human sperm function and infertility. Here, we report for the first time the most plausible underlying mechanism for this unwarranted secondary mode of action. We followed up on a recent serendipitous discovery in our laboratory regarding PPIs' off-target action and performed detailed pharmacodynamic analyses by combining in silico and in vitro studies to determine the off-target effect of one of the most commonly used PPI, esomeprazole, on the key human acetylcholine biosynthesizing enzyme, choline acetyltransferase (ChAT; EC 2.3.1.6). A pivotal enzyme in the spermic cholinergic system that governs the sperm motility, concentration and quality. Our results were conclusive and showed that both the racemic form, omeprazole and its pure S-enantiomer, esomeprazole, acted as potent mixed-competitive inhibitor of human ChAT with a global inhibition constant (K
i ) of 88 nM (95%CI: 10-167 nM) for esomeprazole and 178 nM (95%CI: 140-230 nM) for the racemic drug omeprazole. Most importantly, esomeprazole substantially reduces both total number of motile sperm (by 36%, p < 0.001; and 21% p < 0.0001, at 10 and 100 nM, respectively) as well as the total number of sperm with progressive motility (by 42% p < 0.0016 and by 26% p < 0.0001, respectively) after 60 min relative to 20 min incubation in our ex vivo functional assay performed on ejaculated human sperm. In conclusion, this study presents a completely new perspective regarding PPIs secondary mode of action/unwarranted side effects and calls for further mechanistic and larger clinical studies to elucidate the role of PPIs in infertility., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
41. Assessment of Oligo-Chitosan Biocompatibility toward Human Spermatozoa.
- Author
-
Schimpf U, Nachmann G, Trombotto S, Houska P, Yan H, Björndahl L, and Crouzier T
- Subjects
- Adenosine Triphosphate chemistry, Biocompatible Materials adverse effects, Chitosan adverse effects, Chitosan chemistry, DNA Damage drug effects, Glycolysis drug effects, Humans, Male, Membrane Potential, Mitochondrial drug effects, Polymers chemistry, Polymers pharmacology, Reactive Oxygen Species chemistry, Biocompatible Materials pharmacology, Chitosan pharmacology, Mitochondria drug effects, Spermatozoa drug effects
- Abstract
The many interesting properties of chitosan polysaccharides have prompted their extensive use as biomaterial building blocks, for instance as antimicrobial coatings, tissue engineering scaffolds, and drug delivery vehicles. The translation of these chitosan-based systems to the clinic still requires a deeper understanding of their safety profiles. For instance, the widespread claim that chitosans are spermicidal is supported by little to no data. Herein, we thoroughly investigate whether chitosan oligomer (CO) molecules can impact the functional and structural features of human spermatozoa. By using a large number of primary sperm cell samples and by isolating the effect of chitosan from the effect of sperm dissolution buffer, we provide the first realistic and complete picture of the effect of chitosans on sperms. We found that CO binds to cell surfaces or/and is internalized by cells and affected the average path velocity of the spermatozoa, in a dose-dependent manner. However, CO did not affect the progressive motility, motility, or sperm morphology, nor did it cause loss of plasma membrane integrity, reactive oxygen species production, or DNA damage. A decrease in spermatozoa adenosine triphosphate levels, which was especially significant at higher CO concentrations, points to possible interference of CO with mitochondrial functions or the glycolysis processes. With this first complete and in-depth look at the spermicidal activities of chitosans, we complement the complex picture of the safety profile of chitosans and inform on further use of chitosans in biomedical applications.
- Published
- 2019
- Full Text
- View/download PDF
42. Possible factors influencing post-ejaculatory changes of the osmolality of human semen in vitro.
- Author
-
Holmes E, Björndahl L, and Kvist U
- Subjects
- Humans, Male, Osmolar Concentration, Specimen Handling, Spermatozoa, Semen chemistry
- Abstract
The human ejaculate is made up of secretions from the different accessory sex glands that empty in sequence at ejaculation. However, the different secretions only mix completely in vitro when the entire ejaculate is collected in a container and handled in the laboratory. At ejaculation, proteins from the seminal vesicles form a gel in the ejaculate and semen cannot be properly analysed and processed until the gel is liquefied. During and after liquefaction, there is continuous enzymatic activities and an ongoing increase in osmolality. The aim of this study was to investigate possible factors that influence the increase in semen osmolality in vitro. Osmolality was measured by freezing-point depression. Prostatic secretion was measured as zinc concentration. The presence of spermatozoa neither influenced the actual measurement of semen osmolality, nor the increase in osmolality. Enzymatic inhibitors reduced the increase in osmolality, and semen dilution prevented any increase in semen osmolality. However, the increase in osmolality covaried with the seminal zinc concentration, indicating that the observed increase was related to factors of prostatic origin. A simple and convenient procedure to reduce the risk for osmotic challenges for spermatozoa during handling for assisted reproductive technologies might be early dilution of semen., (© 2019 Blackwell Verlag GmbH.)
- Published
- 2019
- Full Text
- View/download PDF
43. Post-ejaculatory increase in human semen osmolality in vitro.
- Author
-
Holmes E, Björndahl L, and Kvist U
- Subjects
- Ejaculation, Humans, Male, Osmolar Concentration, Temperature, Time Factors, Reproductive Techniques, Assisted, Semen chemistry, Specimen Handling, Spermatozoa chemistry
- Abstract
Spermatozoa prepared in vitro for assisted reproductive technology (ART) encounter other challenges than in vivo. One could be to survive and function despite varying extracellular osmolality. There is a lack of consistent knowledge of human semen osmolality and changes after liquefaction. The aim of this study was to investigate changes in semen osmolality that may occur in vitro after ejaculation and during sperm handling for ART. Osmolality was measured in 86 semen samples by freezing-point depression during storage in vitro at various times and temperatures. The freezing-point depression method was robust and reliable for measuring the osmolality of whole semen as shown by a low variability between repeats. At ejaculation, the osmolality was isotonic to cervical mucus and body fluids. There was a marked increase in osmolality after liquefaction, and the degree of increase varied greatly between samples. Osmolality rose with increasing temperature, and the progressive increase was blocked by denaturising temperature. Spermatozoa in each individual semen sample experienced a highly variable environment in vitro with respect to osmolality. This may be of importance regarding the handling of semen samples for the outcome of ART., (© 2019 Blackwell Verlag GmbH.)
- Published
- 2019
- Full Text
- View/download PDF
44. Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden.
- Author
-
Levine H, Mohri H, Ekbom A, Ramos L, Parker G, Roldan E, Jovine L, Koelle S, Lindstrand A, Immler S, Mortimer S, Mortimer D, van der Horst G, Ishijima S, Aneck-Hahn N, Baldi E, Menkveld R, Rothmann SA, Giwercman A, Giwercman Y, Holmberg M, Kvist U, Björndahl L, Holmberg R, Arver S, Flanagan J, and Drevet JR
- Abstract
On the occasion of the XIIIth International Symposium on Spermatology held from 9 to 13 May 2018 in Stockholm (Sweden), participants (guest speakers and audience) collectively felt the need to make a public statement on the general issue of male reproductive health. Our intention is to raise awareness of what we believe is a neglected area of research despite alarming situations around the world. The disclosure strategy desired by the co-authors is to bring it to the attention of the greatest number partly by considering co-publication in the various periodicals dealing with Reproductive Biology and Andrology. BaCA's editorial office accepted this mission and found it natural that our periodical, the official journal of the French Andrology Society (SALF), should carry this message., Competing Interests: Not applicable.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- Published
- 2018
- Full Text
- View/download PDF
45. The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities.
- Author
-
Barratt CLR, Björndahl L, De Jonge CJ, Lamb DJ, Osorio Martini F, McLachlan R, Oates RD, van der Poel S, St John B, Sigman M, Sokol R, and Tournaye H
- Subjects
- Genetic Testing, Humans, Infertility, Male complications, Infertility, Male genetics, Male, Practice Guidelines as Topic, Semen Analysis, Varicocele complications, World Health Organization, Infertility, Male diagnosis
- Abstract
Background: Herein, we describe the consensus guideline methodology, summarize the evidence-based recommendations we provided to the World Health Organization (WHO) for their consideration in the development of global guidance and present a narrative review of the diagnosis of male infertility as related to the eight prioritized (problem or population (P), intervention (I), comparison (C) and outcome(s) (O) (PICO)) questions. Additionally, we discuss the challenges and research gaps identified during the synthesis of this evidence., Objective and Rationale: The aim of this paper is to present an evidence-based approach for the diagnosis of male infertility as related to the eight prioritized PICO questions., Search Methods: Collating the evidence to support providing recommendations involved a collaborative process as developed by WHO, namely: identification of priority questions and critical outcomes; retrieval of up-to-date evidence and existing guidelines; assessment and synthesis of the evidence; and the formulation of draft recommendations to be used for reaching consensus with a wide range of global stakeholders. For each draft recommendation the quality of the supporting evidence was then graded and assessed for consideration during a WHO consensus., Outcomes: Evidence was synthesized and recommendations were drafted to address the diagnosis of male infertility specifically encompassing the following: What is the prevalence of male infertility and what proportion of infertility is attributable to the male? Is it necessary for all infertile men to undergo a thorough evaluation? What is the clinical (ART/non ART) value of traditional semen parameters? What key male lifestyle factors impact on fertility (focusing on obesity, heat and tobacco smoking)? Do supplementary oral antioxidants or herbal therapies significantly influence fertility outcomes for infertile men? What are the evidence-based criteria for genetic screening of infertile men? How does a history of neoplasia and related treatments in the male impact on (his and his partner's) reproductive health and fertility options? And lastly, what is the impact of varicocele on male fertility and does correction of varicocele improve semen parameters and/or fertility?, Wider Implications: This evidence synthesis analysis has been conducted in a manner to be considered for global applicability for the diagnosis of male infertility., (© The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.)
- Published
- 2017
- Full Text
- View/download PDF
46. 'How to count sperm properly': checklist for acceptability of studies based on human semen analysis.
- Author
-
Björndahl L, Barratt CL, Mortimer D, and Jouannet P
- Subjects
- Editorial Policies, Humans, Male, Periodicals as Topic, Semen Analysis methods, Checklist, Semen Analysis standards
- Abstract
Study Question: Can a tool be developed for authors, reviewers and editors of the ESHRE Journals to improve the quality of published studies which rely on semen analysis data?, Summary Answer: A basic checklist for authors, reviewers and editors has been developed and is presented., What Is Known Already: Laboratory work which includes semen analysis is burdened by a lack of standardization. This has significant negative effects on the quality of scientific and epidemiological studies, potential misclassification of patients and the potential to impair clinical treatments/diagnoses that rely on accurate semen quality information. Robust methods are available to reduce laboratory error in semen analysis, inducing adherence to World Health Organization techniques, participation in an external quality control scheme and appropriate training of laboratory personnel. However, journals have not had appropriate systems to assess if these methods have been used., Study Design, Size, Duration: After discussion at a series of Associate Editor Meetings of the ESHRE Journals the authors of the present text were asked to propose a tool for authors, reviewers and editors of the ESHRE Journals to ensure a high quality assessment of submitted manuscripts which rely on semen analysis data, including a detailed verification of the relevance and the quality of the methods used., Participants/materials, Setting, Methods: N/A., Main Results and the Role of Chance: A basic checklist for authors, reviewers and editors is presented. The checklist contains key points which should be considered by authors when designing studies and which provides essential information for when the submitted manuscript is evaluated. For published articles the answers in the checklist are suitable to be available as supplementary data, which will also reduce the space necessary for technical details in the printed article., Limitations, Reasons for Caution: Guidelines such as these should not be used uncritically. It is therefore important that submitting authors, in situations where their study does not comply with the basic requirements for semen analysis, not only explain all methodological deviations but also declare the level of uncertainty in their analyses and how it complies with, or might confound, the aims of the study., Wider Implications of the Findings: The fundamental importance of appropriate and robust methodology to facilitate advances in scientific understanding and patient management and treatment, is now accepted as being paramount. Use of the semen analysis checklist should be part of this process, and when completed and signed by the corresponding author at the time of submitting a manuscript should result in greater transparency, and ultimately uniformity. It is hoped that this initiative will pave the way for wider adoption of the methodology/reporting by other biomedical, epidemiological and scientific journals, and ultimately become the standard of practice for papers reporting semen analysis results obtained in laboratory and clinical andrology. Systems to assist referees, authors and editors to present high quality findings should have a significant impact on the field of reproductive medicine., Study Funding/competing Interests: No funding was obtained for this work. The authors have no competing interests in relation to the present publication and checklist., Trial Registration Number: N/A., (© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
47. Structure of chromatin in spermatozoa.
- Author
-
Björndahl L and Kvist U
- Subjects
- Animals, Chromatin metabolism, Chromatin ultrastructure, DNA Damage physiology, Genomic Instability physiology, Humans, Male, Nucleic Acid Conformation, Protamines metabolism, Spermatozoa ultrastructure, Zinc metabolism, Chromatin chemistry, Spermatozoa metabolism
- Abstract
The specialized structure of the sperm chromatin has a dual function - first to protect the DNA from damage during storage and transport to the oocyte, and then to enable a rapid and complete unpacking of the undamaged paternal genome in the ooplasm. It is evident that zinc has a pivotal role in maintaining the structural stability and in enabling a rapid decondensation at the appropriate time. It is important for the sperm chromatin structure that the spermatozoa are ejaculated together with the zinc-rich prostatic secretion. Early exposure to zinc-binding seminal vesicular fluid can deplete the sperm chromatin of zinc and most likely induce surplus formation of disulfide bridges, likely to cause incomplete and delayed decondensation of the sperm chromatin in the oocyte. A premature decrease in sperm chromatin structure stability is likely to increase the risk for damage to the DNA due to increased access to the genome for DNA damaging compounds. The status of the sperm chromatin structure can vary in vitro depending on the exposure to zinc-depleting conditions when spermatozoa are stored in semen after ejaculation. When sperm DNA damage tests are evaluated and validated, it is therefore essential to also take into account the dynamics of zinc-dependent and zinc-independent sperm chromatin stability.
- Published
- 2014
- Full Text
- View/download PDF
48. What should it take to describe a substance or product as 'sperm-safe'.
- Author
-
Mortimer D, Barratt CL, Björndahl L, de Jager C, Jequier AM, and Muller CH
- Subjects
- Humans, Male, Safety, Sperm Count, Sperm Motility drug effects, Sperm Motility radiation effects, Spermatozoa cytology, Spermatozoa physiology, Toxicity Tests, Environmental Exposure, Environmental Pollutants toxicity, Fertility drug effects, Infertility, Male chemically induced, Spermatozoa drug effects, Xenobiotics toxicity
- Abstract
Background: Male reproductive potential continues to be adversely affected by many environmental, industrial and pharmaceutical toxins. Pre-emptive testing for reproductive toxicological (side-)effects remains limited, or even non-existent. Many products that come into direct contact with spermatozoa lack adequate testing for the absence of adverse effects, and numerous products that are intended for exposure to spermatozoa have only a general assumption of safety based on the absence of evidence of actual harm. Such assumptions can have unfortunate adverse impacts on at-risk individuals (e.g. couples who are trying to conceive), illustrating a clear need for appropriate up-front testing to establish actual 'sperm safety'., Methods: After compiling a list of general areas within the review's scope, relevant literature and other information was obtained from the authors' personal professional libraries and archives, and supplemented as necessary using PubMed and Google searches. Review by co-authors identified and eliminated errors of omission or bias., Results: This review provides an overview of the broad range of substances, materials and products that can affect male fertility, especially through sperm fertilizing ability, along with a discussion of practical methods and bioassays for their evaluation. It is concluded that products can only be claimed to be 'sperm-safe' after performing objective, properly designed experimental studies; extrapolation from supposed predicate products or other assumptions cannot be trusted., Conclusions: We call for adopting the precautionary principle, especially when exposure to a product might affect not only a couple's fertility potential but also the health of resulting offspring and perhaps future generations.
- Published
- 2013
- Full Text
- View/download PDF
49. Methods for sperm concentration determination.
- Author
-
Björndahl L
- Subjects
- Humans, Male, Practice Guidelines as Topic, Sperm Count instrumentation, Sperm Count standards, Sperm Count methods
- Abstract
Proper assessment of the number of spermatozoa is essential not only as an initial step in every clinical infertility investigation [Björndahl et al (2010) A practical guide to basic laboratory andrology, 1st edn. Cambridge University Press, Cambridge] but also when attempting to establish the total sperm production in the testis [Amann (Hum Reprod 25:22-28, 2010); Amann (J Androl 30:626-641, 2009); Amann and Chapman (J Androl 30:642-649, 2009)]. Reliable methods combined with an understanding of the specific physiology involved as well as the main sources of errors related to the assessment of sperm concentration are critical for ensuring accurate concentration determination [Björndahl et al (2010) A practical guide to basic laboratory andrology, 1st edn. Cambridge University Press, Cambridge; World Health Organization (2010) WHO laboratory manual for the examination and processing of human semen. WHO, Geneva]. This chapter therefore focuses on these three aspects.
- Published
- 2013
- Full Text
- View/download PDF
50. [Swedish Andrological Society on testosterone: misunderstood, mythical and a part of men's health].
- Author
-
Arver S, Giwercman A, Link K, Pousette A, Abramsson L, Björndahl L, Gottlieb C, and Elzanaty S
- Subjects
- Andrology, Evidence-Based Medicine, Humans, Hypogonadism diagnosis, Hypogonadism therapy, Male, Practice Guidelines as Topic, Sweden, Men's Health, Societies, Medical, Testosterone adverse effects, Testosterone deficiency, Testosterone therapeutic use
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.